FDA Updates HIV Drug Info to Include MI Danger

Courtesy MedPage Today Infectious Disease  Fri, 12/04/2009 - 10:04

WASHINGTON (MedPage Today) -- The FDA has added increased risk of myocardial infarction and dyslipidemia to prescribing information for the HIV drug fosamprenavir calcium (Lexiva) in tablet and oral suspension.


 

More related items

Door-to-Balloon Time Shorter With EMT Diagnosis...
(MedPage Today) -- Emergency medical technicians usually make the right call when assessing patients for suspected ST-elevation myocardial infarction (STEMI), according to data from a...

Web-Based Program Fails to Boost Care After MI...
(MedPage Today) -- An Internet-based intervention intended to improve post-myocardial infarction care failed to significantly change provider behavior, a large longitudinal study showed.

K2 Linked to Heart Attacks in Teens (CME/CE)
(MedPage Today) -- Physicians who encounter myocardial infarction in teenagers should consider the possibility that the teens may have ingested K2, a form of synthetic cannabinoid,...

Alcohawk Precision Digital Alcohol Breath Tester
The Precision is a (DOT) (NHTSA) approved professional-grade alcohol screener, which utilizes a state-of-the-art semiconductor sensor to test breath alcohol content quickly and accurately....

Genuine Magnetrainer ER (Extended Range) Mini...
This is a Genuine MagneTrainer Extended Range mini exercise bike. The MagneTrainer is the highest quality portable exercise bike in it's price range, guaranteed. If you find a better bike in...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com